Annual CFF:
-$11.74B+$2.54B(+17.81%)Summary
- As of today, NVS annual cash from financing is -$11.74 billion, with the most recent change of +$2.54 billion (+17.81%) on December 31, 2024.
- During the last 3 years, NVS annual cash from financing has risen by +$4.53 billion (+27.84%).
- NVS annual cash from financing is now -387.43% below its all-time high of $4.08 billion, reached on December 31, 2010.
Performance
NVS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$2.75B+$2.60B(+48.55%)Summary
- As of today, NVS quarterly cash from financing is -$2.75 billion, with the most recent change of +$2.60 billion (+48.55%) on September 29, 2025.
- Over the past year, NVS quarterly cash from financing has dropped by -$2.37 billion (-621.06%).
- NVS quarterly cash from financing is now -138.72% below its all-time high of $7.11 billion, reached on September 30, 2010.
Performance
NVS Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$19.65B-$2.37B(-13.73%)Summary
- As of today, NVS TTM cash from financing is -$19.65 billion, with the most recent change of -$2.37 billion (-13.73%) on September 29, 2025.
- Over the past year, NVS TTM cash from financing has dropped by -$10.30 billion (-110.12%).
- NVS TTM cash from financing is now -347.69% below its all-time high of $7.93 billion, reached on September 30, 2010.
Performance
NVS TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +17.8% | -621.1% | -110.1% |
| 3Y3 Years | +27.8% | +41.9% | +0.8% |
| 5Y5 Years | +13.9% | -245.0% | -4037.3% |
NVS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +42.9% | -621.1% | +70.1% | -110.1% | +9.1% |
| 5Y | 5-Year | -431.5% | +42.9% | -245.0% | +71.1% | -4037.3% | +9.1% |
| All-Time | All-Time | -387.4% | +42.9% | -138.7% | +71.5% | -347.7% | +9.1% |
NVS Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$2.75B(+48.6%) | -$19.65B(-13.7%) |
| Jun 2025 | - | -$5.35B(+37.4%) | -$17.28B(-14.2%) |
| Mar 2025 | - | -$8.55B(-185.3%) | -$15.13B(-28.8%) |
| Dec 2024 | -$11.74B(+17.8%) | -$3.00B(-684.3%) | -$11.74B(-25.5%) |
| Sep 2024 | - | -$382.00M(+88.1%) | -$9.35B(+4.6%) |
| Jun 2024 | - | -$3.20B(+38.0%) | -$9.80B(+4.2%) |
| Mar 2024 | - | -$5.16B(-750.7%) | -$10.23B(+28.4%) |
| Dec 2023 | -$14.28B(+30.6%) | -$607.00M(+27.0%) | -$14.29B(+19.3%) |
| Sep 2023 | - | -$832.00M(+77.1%) | -$17.72B(+18.1%) |
| Jun 2023 | - | -$3.63B(+60.7%) | -$21.62B(-6.5%) |
| Mar 2023 | - | -$9.22B(-128.6%) | -$20.30B(+1.5%) |
| Dec 2022 | -$20.56B(-26.4%) | -$4.03B(+14.9%) | -$20.60B(-4.0%) |
| Sep 2022 | - | -$4.74B(-105.8%) | -$19.82B(-19.3%) |
| Jun 2022 | - | -$2.30B(+75.8%) | -$16.61B(+3.7%) |
| Mar 2022 | - | -$9.53B(-193.1%) | -$17.25B(-6.1%) |
| Dec 2021 | -$16.26B(-636.6%) | -$3.25B(-111.9%) | -$16.26B(-2.0%) |
| Sep 2021 | - | -$1.53B(+47.8%) | -$15.95B(-27.4%) |
| Jun 2021 | - | -$2.94B(+65.6%) | -$12.52B(-6.4%) |
| Mar 2021 | - | -$8.54B(-190.9%) | -$11.76B(-432.7%) |
| Dec 2020 | -$2.21B(+83.8%) | -$2.94B(-254.5%) | -$2.21B(-364.8%) |
| Sep 2020 | - | $1.90B(+187.0%) | -$475.00M(+90.7%) |
| Jun 2020 | - | -$2.19B(-315.7%) | -$5.09B(-73.6%) |
| Mar 2020 | - | $1.01B(+184.2%) | -$2.93B(+78.5%) |
| Dec 2019 | -$13.63B(-221.1%) | -$1.20B(+55.7%) | -$13.63B(-13.7%) |
| Sep 2019 | - | -$2.71B(-9589.3%) | -$11.98B(-10.0%) |
| Jun 2019 | - | -$28.00M(+99.7%) | -$10.89B(+12.1%) |
| Mar 2019 | - | -$9.68B(-2284.3%) | -$12.39B(-191.3%) |
| Dec 2018 | -$4.24B(+45.1%) | $443.29M(+127.3%) | -$4.25B(+40.0%) |
| Sep 2018 | - | -$1.62B(-5.9%) | -$7.09B(+4.3%) |
| Jun 2018 | - | -$1.53B(+1.0%) | -$7.41B(+16.7%) |
| Mar 2018 | - | -$1.55B(+35.5%) | -$8.89B(-15.0%) |
| Dec 2017 | -$7.73B(-45.5%) | -$2.40B(-23.7%) | -$7.73B(-1.2%) |
| Sep 2017 | - | -$1.94B(+35.7%) | -$7.64B(-26.4%) |
| Jun 2017 | - | -$3.01B(-676.3%) | -$6.04B(-29.3%) |
| Mar 2017 | - | -$388.00M(+83.2%) | -$4.67B(+12.0%) |
| Dec 2016 | -$5.31B(+42.1%) | -$2.30B(-573.4%) | -$5.31B(+8.2%) |
| Sep 2016 | - | -$342.00M(+79.2%) | -$5.79B(+24.3%) |
| Jun 2016 | - | -$1.64B(-59.9%) | -$7.64B(+9.6%) |
| Mar 2016 | - | -$1.03B(+63.0%) | -$8.45B(+7.9%) |
| Dec 2015 | -$9.18B(-12.6%) | -$2.77B(-26.4%) | -$9.18B(-28.5%) |
| Sep 2015 | - | -$2.20B(+10.4%) | -$7.14B(-20.7%) |
| Jun 2015 | - | -$2.45B(-39.6%) | -$5.92B(+3.3%) |
| Mar 2015 | - | -$1.75B(-136.5%) | -$6.12B(+24.9%) |
| Dec 2014 | -$8.15B(+7.1%) | -$742.00M(+23.8%) | -$8.15B(+8.7%) |
| Sep 2014 | - | -$973.25M(+63.3%) | -$8.92B(+4.5%) |
| Jun 2014 | - | -$2.65B(+29.9%) | -$9.34B(-1.6%) |
| Mar 2014 | - | -$3.78B(-149.1%) | -$9.19B(-4.8%) |
| Dec 2013 | -$8.77B | -$1.52B(-9.1%) | -$8.77B(-3.5%) |
| Sep 2013 | - | -$1.39B(+44.4%) | -$8.47B(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$2.50B(+25.5%) | -$9.25B(-10.4%) |
| Mar 2013 | - | -$3.36B(-175.2%) | -$8.38B(-25.6%) |
| Dec 2012 | -$6.67B(+55.1%) | -$1.22B(+43.8%) | -$6.68B(+29.5%) |
| Sep 2012 | - | -$2.17B(-32.7%) | -$9.46B(+12.9%) |
| Jun 2012 | - | -$1.63B(+1.0%) | -$10.86B(+32.1%) |
| Mar 2012 | - | -$1.65B(+58.8%) | -$16.00B(-7.6%) |
| Dec 2011 | -$14.87B(-464.2%) | -$4.01B(-12.3%) | -$14.87B(-0.2%) |
| Sep 2011 | - | -$3.57B(+47.3%) | -$14.84B(-256.9%) |
| Jun 2011 | - | -$6.77B(-1210.9%) | -$4.16B(-217.3%) |
| Mar 2011 | - | -$516.72M(+87.0%) | $3.54B(-13.2%) |
| Dec 2010 | $4.08B(+45.9%) | -$3.98B(-156.0%) | $4.08B(-48.5%) |
| Sep 2010 | - | $7.11B(+666.4%) | $7.93B(+538.7%) |
| Jun 2010 | - | $928.28M(+4119.8%) | $1.24B(-47.5%) |
| Mar 2010 | - | $22.00M(+116.9%) | $2.37B(-15.4%) |
| Dec 2009 | $2.80B(+208.7%) | -$130.05M(-130.8%) | $2.80B(+446.7%) |
| Sep 2009 | - | $422.02M(-79.5%) | -$807.07M(-46.6%) |
| Jun 2009 | - | $2.05B(+354.4%) | -$550.51M(-137.7%) |
| Mar 2009 | - | $452.03M(+112.1%) | $1.46B(+156.8%) |
| Dec 2008 | -$2.57B(+72.4%) | -$3.74B(-650.4%) | -$2.57B(-321.4%) |
| Sep 2008 | - | $678.58M(-83.3%) | $1.16B(+148.3%) |
| Jun 2008 | - | $4.07B(+213.5%) | -$2.41B(+67.0%) |
| Mar 2008 | - | -$3.58B(-24.0%) | -$7.28B(-18.1%) |
| Dec 2007 | -$9.32B(-89.0%) | - | - |
| Sep 2007 | - | -$2.89B(-258.1%) | -$6.16B(-64.7%) |
| Jun 2007 | - | -$806.60M(+67.3%) | -$3.74B(-0.5%) |
| Mar 2007 | - | -$2.47B(-427.1%) | -$3.72B(-206.3%) |
| Dec 2006 | -$4.93B(-1726.3%) | - | - |
| Sep 2006 | - | -$467.93M(+40.6%) | -$1.22B(+8.5%) |
| Jun 2006 | - | -$787.79M(+55.0%) | -$1.33B(-382.7%) |
| Mar 2006 | - | -$1.75B(-197.7%) | $469.87M(+263.8%) |
| Dec 2005 | -$270.00M(+90.9%) | $1.79B(+408.0%) | -$286.93M(+75.6%) |
| Sep 2005 | - | -$581.05M(-157.5%) | -$1.18B(+20.7%) |
| Jun 2005 | - | $1.01B(+140.3%) | -$1.48B(+52.7%) |
| Mar 2005 | - | -$2.51B(-378.5%) | -$3.13B(-5.2%) |
| Dec 2004 | -$2.98B(+47.9%) | $899.59M(+201.3%) | -$2.98B(+23.2%) |
| Sep 2004 | - | -$887.67M(-38.7%) | -$3.88B(-29.7%) |
| Jun 2004 | - | -$639.95M(+72.8%) | -$2.99B(-27.2%) |
| Mar 2004 | - | -$2.35B(-363.7%) | -$2.35B(-363.7%) |
| Dec 2003 | -$5.72B(-34.5%) | - | - |
| Dec 2002 | -$4.25B(-1928.7%) | $892.11M | $892.11M |
| Dec 2001 | -$209.66M(+92.5%) | - | - |
| Dec 2000 | -$2.81B(+2.0%) | - | - |
| Dec 1999 | -$2.87B(+33.5%) | - | - |
| Dec 1998 | -$4.32B(-140.0%) | - | - |
| Dec 1997 | -$1.80B(-26.9%) | - | - |
| Dec 1996 | -$1.42B(-4831.3%) | - | - |
| Dec 1995 | -$28.79M(-101.8%) | - | - |
| Dec 1994 | $1.57B(+173.6%) | - | - |
| Dec 1993 | $573.85M | - | - |
FAQ
- What is Novartis AG annual cash from financing?
- What is the all-time high annual cash from financing for Novartis AG?
- What is Novartis AG annual cash from financing year-on-year change?
- What is Novartis AG quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Novartis AG?
- What is Novartis AG quarterly cash from financing year-on-year change?
- What is Novartis AG TTM cash from financing?
- What is the all-time high TTM cash from financing for Novartis AG?
- What is Novartis AG TTM cash from financing year-on-year change?
What is Novartis AG annual cash from financing?
The current annual cash from financing of NVS is -$11.74B
What is the all-time high annual cash from financing for Novartis AG?
Novartis AG all-time high annual cash from financing is $4.08B
What is Novartis AG annual cash from financing year-on-year change?
Over the past year, NVS annual cash from financing has changed by +$2.54B (+17.81%)
What is Novartis AG quarterly cash from financing?
The current quarterly cash from financing of NVS is -$2.75B
What is the all-time high quarterly cash from financing for Novartis AG?
Novartis AG all-time high quarterly cash from financing is $7.11B
What is Novartis AG quarterly cash from financing year-on-year change?
Over the past year, NVS quarterly cash from financing has changed by -$2.37B (-621.06%)
What is Novartis AG TTM cash from financing?
The current TTM cash from financing of NVS is -$19.65B
What is the all-time high TTM cash from financing for Novartis AG?
Novartis AG all-time high TTM cash from financing is $7.93B
What is Novartis AG TTM cash from financing year-on-year change?
Over the past year, NVS TTM cash from financing has changed by -$10.30B (-110.12%)